China, Nov. 6 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of Efficacy and Safety of Preoperative Intravitreal Injection of Two Anti-Vascular Endothelial Growth Factor Drugs in the Treatment of Proliferative Diabetic Retinopathy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136128
Registration Time: 2026/11/05
Type: Observational study
Primary Sponsor: Tianjin Medical University Eye Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351314
Published by HT Digital Content Services with permission from Health Daily Digest....